US8062679B2ActiveUtilityA1

Composition for maintaining androgen and androgen-like uptake potential by cells

72
Assignee: CLEMENT KENPriority: May 10, 2007Filed: May 10, 2007Granted: Nov 22, 2011
Est. expiryMay 10, 2027(~0.8 yrs left)· nominal 20-yr term from priority
A61P 21/06A61K 31/122A23L 33/175A23L 33/105A61K 36/53A61K 31/205A61K 36/071
72
PatentIndex Score
2
Cited by
46
References
1
Claims

Abstract

A composition comprising at least a therapeutically effective amount of L-carnitine fumarate, and an extract of Coleus forskohlii is provided to maintain androgen and androgen-like uptake potential in cells, via simultaneous increase in the availability of androgen receptors and improved availability of androgen and androgen-like molecules. A method of same is also provided. The present invention further comprises therapeutically effective amounts of one or more of N-acetyl L-carnitine, melatonin. ubidecarenone (coenzyme Q10), idebenone, decylubiquinone, an extract of Agaricus blazei Murill , and ginsenoside Rb1.

Claims

exact text as granted — not AI-modified
1. A composition for maintaining androgen and androgen-like substance uptake potential in cells, wherein said composition consists essentially of about 1.25 g of L-carnitine fumarate, about 0.025 g of an extract of  Coleus forskohlii  standardized to 10% forskolin, about 0.375 g of N-acetyl L-carnitine, about 0.0005 g of melatonin, about 0.001 g of ubidecarenone (coenzyme Q10), about 0.001 g of idebenone, about 0.00001 g of decylubiquinone, about 0.001 g of an extract of  Agaricus blazei Murill , and about 0.00005 g of ginsenoside Rb1.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.